StonvexLoading…
StonvexStonvexStonvexCore line items from SARO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.63B | $6.06B | $4.46B | $2.96B |
Operating Income | $143.10M | $551.07M | $401.83M | $264.49M |
Net Income | $79.93M | $277.42M | $198.78M | $67.71M |
EPS (Diluted) | $0.24 | $0.83 | $0.59 | $0.39 |
Total Assets | $6.70B | $6.56B | $6.65B | $6.48B |
Total Liabilities | $4.02B | $3.89B | $4.06B | $3.97B |
Cash & Equivalents | $89.17M | $289.72M | $97.50M | $91.51M |
Free Cash Flow OCF − CapEx | $-135.15M | $234.30M | $-73.04M | $-68.36M |
Shares Outstanding | 332.27M | 334.29M | 334.47M | 334.47M |